Pancreatic Cancer Research

ResearcherState Key Laboratory of Pharmaceutical BiotechnologyActive in the last 2 years

Jiatong Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4062-1157; OpenAlex author ID A5102560008. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2025: 3 papers

Papers 3

  1. SP1-Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer. Co-author DOI 10.1002/advs.202510071↗
  2. CD44 identified as a diagnostic biomarker for highly malignant CA19-9 negative pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217713↗
  3. Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer. Co-author DOI 10.1136/jitc-2025-013269↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Neng Tang · 2 shared papers, 2025 · strength 0.39
  2. Chao Yan · 2 shared papers, 2025 · strength 0.39
  3. Hexing Hang · 2 shared papers, 2025 · strength 0.39
  4. Hao Cheng · 2 shared papers, 2025 · strength 0.39
  5. Qi Li · 2 shared papers, 2025 · strength 0.38
  6. Yixuan Zhang · 1 shared paper, 2025 · strength 0.20
  7. Wei Wei · 1 shared paper, 2025 · strength 0.20
  8. Yudong Qiu · 1 shared paper, 2025 · strength 0.20
  9. Shijin Xu · 1 shared paper, 2025 · strength 0.19
  10. Lei Wang · 1 shared paper, 2025 · strength 0.19
  11. Yixuan Zhang · 1 shared paper, 2025 · strength 0.19
  12. Xiaoping Zou · 1 shared paper, 2025 · strength 0.19
  13. Ying Lv · 1 shared paper, 2025 · strength 0.19
  14. Shu Zhang · 1 shared paper, 2025 · strength 0.19
  15. Linxi Zhu · 1 shared paper, 2025 · strength 0.19
  16. Yudong Qiu · 1 shared paper, 2025 · strength 0.19
  17. Xiao Fu · 1 shared paper, 2025 · strength 0.19
  18. Zhenghua Cai · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.